Canada Pension Plan Investment Board increased its stake in Danaher Corporation (NYSE:DHR - Free Report) by 24.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,894,076 shares of the conglomerate's stock after acquiring an additional 374,737 shares during the quarter. Canada Pension Plan Investment Board owned 0.26% of Danaher worth $388,286,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the stock. Parnassus Investments LLC increased its stake in shares of Danaher by 23.3% in the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate's stock valued at $784,745,000 after acquiring an additional 722,636 shares in the last quarter. WPG Advisers LLC bought a new stake in shares of Danaher in the 1st quarter valued at $100,000. Northstar Financial Companies Inc. increased its stake in shares of Danaher by 7.6% in the 1st quarter. Northstar Financial Companies Inc. now owns 1,071 shares of the conglomerate's stock valued at $220,000 after acquiring an additional 76 shares in the last quarter. Okabena Investment Services Inc. bought a new stake in shares of Danaher in the 1st quarter valued at $533,000. Finally, OMERS ADMINISTRATION Corp increased its stake in Danaher by 5.3% during the 1st quarter. OMERS ADMINISTRATION Corp now owns 52,859 shares of the conglomerate's stock valued at $10,836,000 after purchasing an additional 2,657 shares in the last quarter. Institutional investors own 79.05% of the company's stock.
Insider Activity
In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.
Danaher Stock Performance
Shares of DHR stock opened at $205.42 on Friday. The firm has a 50-day moving average of $201.45 and a 200-day moving average of $199.48. The company has a market cap of $147.09 billion, a P/E ratio of 43.71, a P/E/G ratio of 2.86 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90.
Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same quarter last year, the business earned $1.72 earnings per share. The company's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of analysts have commented on DHR shares. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research note on Friday, July 11th. Wells Fargo & Company decreased their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Guggenheim restated a "buy" rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Evercore ISI decreased their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $247.61.
Read Our Latest Report on DHR
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.